0.13% 0.0751

Simulations Plus Inc (SLP)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt SLP? Forum Prognose Aktiensplit Dividendenhistorie

Schlusskurs vom Vortag:

24-Stunden-Volumen:

Relative Volume:

Marktkapitalisierung:

Nettoeinkommen (Verlust:

Netto-Cashflow:

1W Leistung:

1M Leistung:

6M Leistung:

1J Leistung:

1-Tages-Spanne:

1-Wochen-Bereich:

52-Wochen-Spanne:

Simulations Plus Inc Stock (SLP) Company Profile

Simulations Plus Inc

Healthcare (1107)

661-723-7723

800 PARK OFFICES DRIVE, SUITE 401, RESEARCH TRIANGLE PARK, CA

@SimulationsPlus

Nächster Verdiensttermin

Neueste SEC-Einreichungen

SLP's Discussions on Twitter

Compare SLP vs VEEV, BTSG, TEM, HQY, DOCS

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
SLP Simulations Plus Inc	15.85	317.43M	80.54M	-62.79M	20.76M	-3.1233
VEEV Veeva Systems Inc	170.04	27.94B	3.20B	908.91M	1.39B	5.4168
BTSG Brightspring Health Services Inc	52.19	9.98B	13.65B	169.86M	412.12M	1.0758
TEM Tempus Ai Inc	50.51	9.70B	1.27B	-245.03M	-245.36M	-1.4071
HQY Healthequity Inc	83.15	6.98B	1.31B	215.20M	408.32M	2.4627
DOCS Doximity Inc	25.44	4.76B	637.78M	239.40M	307.21M	1.1909

Simulations Plus Inc Stock (SLP) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-12-18	Herabstufung	BTIG Research	Buy → Neutral
2025-09-30	Eingeleitet	TD Cowen	Hold
2025-07-15	Herabstufung	KeyBanc Capital Markets	Overweight → Sector Weight
2024-11-15	Eingeleitet	Stephens	Overweight
2024-07-29	Eingeleitet	KeyBanc Capital Markets	Overweight
2024-07-16	Eingeleitet	JMP Securities	Mkt Perform
2024-06-28	Eingeleitet	William Blair	Outperform
2023-05-09	Eingeleitet	BTIG Research	Buy
2021-10-26	Hochstufung	Craig Hallum	Hold → Buy
2021-01-12	Herabstufung	Craig Hallum	Buy → Hold
2020-10-16	Eingeleitet	Raymond James	Outperform
2020-09-08	Eingeleitet	Oppenheimer	Outperform
2020-01-06	Eingeleitet	Craig Hallum	Buy

Alle ansehen

Simulations Plus Inc Aktie (SLP) Neueste Nachrichten

Finanzdaten der Simulations Plus Inc-Aktie (SLP)

Simulations Plus Inc-Aktie (SLP) Insiderhandel

Insiderhandel	Beziehung	Datum	Transaktion	Kosten	#Aktien	Wert ($)	#Aktien Gesamt
WOLTOSZ WALTER S	Director	May 04 '26	Sale	15.13	15,000	226,950	3,267,800

Simulations Plus Inc (SLP)

Simulations Plus Inc Stock (SLP) Company Profile

Compare SLP vs VEEV, BTSG, TEM, HQY, DOCS

Simulations Plus Inc Stock (SLP) Upgrades & Downgrades

Simulations Plus Inc Aktie (SLP) Neueste Nachrichten

Simulations Plus partners with Nvidia on AI drug development By Investing.com - Investing.com Canada

Simulations Plus stock surges 28% on NVIDIA collaboration - Investing.com

NVIDIA tie-up targets up to 75% faster drug-modeling workflows - Stock Titan

Insider Sell Alert: DiBella John Anthony II Sells Shares of Simu - GuruFocus

[Form 4] Simulations Plus, Inc. Insider Trading Activity - Stock Titan

Simulations Plus (SLP) insiders sell 15,000 shares in planned trade - Stock Titan

Do options traders know something about Simulations Plus stock we don't? - MSN

[144] Simulations Plus, Inc. SEC Filing - Stock Titan

(SLP) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily

Do Options Traders Know Something About Simulations Plus Stock We Don't? - TradingView

Simulations Plus (SLP) director receives 2,117-share equity grant as compensation - Stock Titan

Director Sharlene Evans receives 2,117 SLP shares in equity grant - Stock Titan

Director at Simulations Plus (SLP) receives 2,117-share stock grant - Stock Titan

Simulations Plus (SLP) director awarded 2,117 shares as equity compensation - Stock Titan

SLP Stock Price, Quote & Chart | SIMULATIONS PLUS INC (NASDAQ:SLP) - ChartMill

AI in Predictive Toxicology Research Report 2026 Featuring - GlobeNewswire

AI in Predictive Toxicology Research Report 2026 Featuring Certara, Schrodinger, Instem, Simulations Plus, Lhasa, ChemaxonGlobal Forecast to 2030 and 2035 - Yahoo Finance UK

Global Biosimulation Market Poised for Phenomenal Expansion at a CAGR of ~17% by 2034 | DelveInsight - GlobeNewswire Inc.

Simulations Plus, Inc. (NASDAQ:SLP) Receives Consensus Rating of "Hold" from Brokerages - MarketBeat

Latest SLP NewsSimulations Plus Announces Quarterly Cash Di... - Stock Titan

Simulations Plus Q2 2026 earnings preview - MSN

Certara Strategic Business Divestiture Comes At Right Time, Says Analyst - Sahm

(SLP) Risk Channels and Responsive Allocation - Stock Traders Daily

Simulations Plus shares drop over 12% premarket as Q3 revenue forecast misses expectations - MSN

SLP Simulations Plus posts strong Q1 2026 results, shares rise over four percent on double digit EPS and revenue gains.Debt/Equity - Xã Thanh Hà

Simulations Plus partners with Lonza and FDA on drug formulation research - Investing.com Nigeria

Simulations Plus (SLP) Partners with FDA and Lonza for Drug Perf - GuruFocus

Simulations Plus enters funded research collaboration with Lonza, FDA - TipRanks

Simulations Plus partners with Lonza and FDA on drug formulation research By Investing.com - Investing.com South Africa

Simulations Plus Announces Collaboration with Lonza and U.S. FDA to Advance Predictive Frameworks for Complex Oral Drug Products - Business Wire

Craig-Hallum Maintains Simulations Plus(SLP.US) With Buy Rating - Moomoo

Simulations Plus (SLP) Completes Successful Spring School Traini - GuruFocus

What Happened to Simulations Plus (SLP) Stock Today (Wavering) 2026-04-20Continuation Signals - Cổng thông tin điện tử tỉnh Tây Ninh

Simulations Plus Expands Global Access to Model-Informed Drug Development Training Through Its 2026 Spring School - 01net

Simulations Plus Inc Announces Completion of 2026 Spring School Global Training Initiative - marketscreener.com

Simulations Plus Reports Strong Fiscal Second Quarter Growth - HarianBasis.co

Here’s Simulations Plus Inc (SLP)’s Vision for AI in Drug Development - Insider Monkey

Simulations Plus, Children's Place and 3 stocks to watch heading into Friday - MSN

Simulations Plus (SLP) Stock Public Float (+1.77%) 2026-04-18Continuation Pattern - Cổng thông tin điện tử tỉnh Tây Ninh

Simulations Plus, Inc. (SLP) Stock Analysis: Exploring a 67.61% Potential Upside in Healthcare Software Solutions - DirectorsTalk Interviews

Simulations Plus, Inc. (NASDAQ: SLP) Q2 2026 earnings call transcript - MSN

Insider Sell: DiBella John Anthony II Sells Shares of Simulations Plus Inc (SLP) - GuruFocus

John Anthony Dibella II Sells 1,000 Shares of Simulations Plus (NASDAQ:SLP) Stock - MarketBeat

DiBella, Simulations Plus CRO, sells $13370 in SLP stock By Investing.com - Investing.com Canada

Simulations Plus (SLP) CRO sells 1,000 shares via Rule 10b5-1 plan - Stock Titan

HTPK platform from Simulations Plus targets smarter early compound selection at DDC - Traders Union

Simulations Plus: Better Quarter, Same Doubts (NASDAQ:SLP) - Seeking Alpha

Simulations Plus integrates 28-day and PBPK data to secure waiver for 90-day dog studies in agrochemicals - Traders Union

Simulations Plus jumps on earnings beat, sees AI boosting biosimulation outlook - MSN

Finanzdaten der Simulations Plus Inc-Aktie (SLP)

Umsatz

Nettogewinn

Free Cashflow

ENV

Simulations Plus Inc-Aktie (SLP) Insiderhandel

Ähnlich wie SLP